Home Therapy for Stroke Rehabilitation Using the HandSOME Exoskeleton (HandSOME)

August 26, 2020 updated by: The Catholic University of America

Home Therapy for Upper Limb Stroke Rehabilitation Using the HandSOME Exoskeleton

This research will evaluate the potential for a novel hand orthosis (HandSOME) to help stroke victims regain functional use of their hand and regain independent living. Participants will use the HandSOME at home regularly for 8 weeks. Clinical evaluations will measure changes from the intervention after the 8 weeks and also at a 3 month followup.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

After stroke, individuals often have great difficulty with using the affected hand in functional tasks. The hand frequently suffers from finger flexor hypertonia as well as finger extensor weakness. This leads to increased difficulty in grasp and release of objects. HandSOME is a light weight wearable hand orthosis that increases range of motion and decreases effort during grasping tasks. The goal of this study is to evaluate the HandSOME device's effectiveness in the rehabilitation of stroke patients through an 8 week intervention. Eligible subjects will use the device daily at home for 8 weeks with one visit per week to the clinic to evaluate progress and troubleshoot problems with the device. The hypotheses are that the gains from the 8 weeks of training will be statistically significant and clinically important (defined as gains of greater than 10% of full scale) in the domains of impairment, function and amount of arm use.

Study Type

Interventional

Enrollment (Actual)

15

Phase

  • Phase 1

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • District of Columbia
      • Washington, District of Columbia, United States, 20010
        • MedStar National Rehabilitation Network

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

21 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Diagnosis of stroke more than six months prior to entry into the study
  2. Impaired ability to open affected the hand
  3. At least trace ability to extend the wrist and fingers

Exclusion Criteria:

  1. Have cognitive deficits that could negatively affect their ability to complete the protocols as evidenced by a score of 24 or less on the Folstein Mini-Mental State Examination
  2. Have excessive pain in any joint of the affected extremity that could limit ability to cooperate with the protocols
  3. Have serious uncontrolled medical problems as judged by the project therapist
  4. Receiving oral or injected antispasticity medications during study treatment
  5. MCP and IP passive extension limit > 30 degrees from full extension
  6. Excessive tone in the fingers and thumb as determined by Ashworth scores >=3

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: HandSOME
The intervention is given to this group.
Participants use the HandSOME orthosis daily for 8 weeks.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Fugl-Meyer Test of Arm Function
Time Frame: Change from baseline Fugl-Meyer score at 2 months
clinical test of arm motor ability and impairment
Change from baseline Fugl-Meyer score at 2 months
Change in Action Research Arm Test
Time Frame: Change from baseline Action Research Arm Test score at 2 months
clinical test of the functional limitations of the upper extremities
Change from baseline Action Research Arm Test score at 2 months
Change in Motor Activity Log
Time Frame: Change from baseline Motor Activity Log score at 2 months
assess the amount and quality of limb use at home
Change from baseline Motor Activity Log score at 2 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Fugl-Meyer Test of Arm Function at followup
Time Frame: Change from baseline Fugl-Meyer score at 5 months
clinical test of arm motor ability and impairment
Change from baseline Fugl-Meyer score at 5 months
Change in Action Research Arm Test at followup
Time Frame: Change from baseline Action Research Arm Test score at 5 months
clinical test of the functional limitations of the upper extremities
Change from baseline Action Research Arm Test score at 5 months
Change in Motor Activity Log at followup
Time Frame: Change from baseline Motor Activity Log score at 5 months
assess the amount and quality of limb use at home
Change from baseline Motor Activity Log score at 5 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 15, 2017

Primary Completion (Actual)

October 7, 2019

Study Completion (Actual)

October 7, 2019

Study Registration Dates

First Submitted

August 21, 2017

First Submitted That Met QC Criteria

August 23, 2017

First Posted (Actual)

August 28, 2017

Study Record Updates

Last Update Posted (Actual)

August 28, 2020

Last Update Submitted That Met QC Criteria

August 26, 2020

Last Verified

August 1, 2020

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

Yes

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stroke

3
Subscribe